Herbas VPB

Print
EN | LT
LT - COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY
EN - COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 45/06 (2006.01)
C07K 16/18 (2013.01)
C07K 16/28 (2006.01)
C07K 16/2896 (2013.01)
C07K 16/18 (2006.01)
A61K2039/505 (2013.01)
C12N 9/24 (2006.01)
C07K2317/734 (2013.01)
A61K 35/00 (2006.01)
A61K 45/06 (2013.01)
A61P 35/02 (2006.01)
C07K2317/24 (2013.01)
A61P 31/12 (2006.01)
C07K2317/41 (2013.01)
C12N 9/24 (2013.01)
C12Y 302/01 (2013.01)
C12Y 302/01051 (2013.01)
A61P 1/04 (2018.01)
A61P 13/12 (2018.01)
A61P 17/06 (2018.01)
A61P 19/02 (2018.01)
A61P 21/04 (2018.01)
A61P 25/00 (2018.01)
A61P 27/02 (2018.01)
A61P 29/00 (2018.01)
A61P 31/12 (2018.01)
A61P 31/14 (2018.01)
A61P 31/18 (2018.01)
A61P 31/20 (2018.01)
A61P 31/22 (2018.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
A61P 37/02 (2018.01)
A61P 7/00 (2018.01)
A61P 3/10 (2018.01)
Y02A 50/30 (2018.01)
European patent
(11) Number of the document 3149045
(13) Kind of document T
(96) European patent application number 15799981.4
Date of filing the European patent application 2015-05-27
(97) Date of publication of the European application 2017-04-05
(45) Date of publication and mention of the grant of the patent 2023-01-18
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/032745
Date 2015-05-27
PCT application publication
(87) Number WO 2015/184009
Date 2015-12-03
Priority applications
(30) Number Date Country code
201462003136 P 2014-05-27 US
201462003104 P 2014-05-27 US
201462003908 P 2014-05-28 US
201462020199 P 2014-07-02 US
201562110338 P 2015-01-30 US
Inventors
(72)
WONG, Chi-Huey , US
WU, Chung-Yi , CN
MA, Che , CN
Grantee
(73) Academia Sinica , 128, Academia Road, Section 2 Nankang, Taipei 11529, TW
Title
(54) COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY
  COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY